on Galenica AG (isin : CH0360674466)
Verfora Acquires Majority Stake in Polish Distributor Qpharma
Verfora, a key player in the Swiss consumer healthcare market, has acquired a 51% stake in Qpharma, a Polish pharmaceutical distributor. This strategic move expands Verfora's presence in Central and Eastern Europe, enhancing its distribution network. Qpharma, with over 20 years in the healthcare market, specializes in prescription drugs, OTC products, and dietary supplements.
The acquisition ties Verfora's marketing expertise with Qpharma's established distribution platform. Qpharma's licenses and market position offer growth potential. The company will continue to be led by CEO Zbyszek Czop, ensuring continuity in operations and strengthening the existing partnership.
Completion is pending regulatory approval, with financial terms undisclosed. This acquisition marks a significant step in Verfora's expansion strategy, aligning with its long-term growth objectives in the European healthcare market.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Galenica AG news